Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mi2000 TICI - Post-market Implantation Study

NCT07897318 is registered in ClinicalTrials.gov with MED-EL Elektromedizinische Geräte GmbH as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07897318 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Mi2000 TICI - Post-market Implantation Study
Lead sponsor
MED-EL Elektromedizinische Geräte GmbH
Phase
Not applicable
Overall status
Recruiting
Start date
November 11, 2026
Completion date
January 31, 2029
Enrollment
22 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

cochlear implantation, hearing loss, binaural

Arms

As registered; 1 arm.

  • TICI recipients ExperimentalCochlear Implantation

    Participants in this clinical investigation will be implanted with an Mi2000 TICI totally cochlear implant

Primary endpoints

Registered primary outcome measures; 2 primary.

  • Word Test in Quiet Pre-op to 6 months after first fitting

    Word recognition in quiet, on a scale from 0 to 100% correct, higher scores indicate better outcomes

  • Sentence Test in Noise Pre-op to 6 months after first fitting

    Oldenburg Matrix Test, results measured in dB signal-to-noise ratio (SNR) with a range of +30 to -10 dB SNR, lower values indicating better outcomes

Lead sponsor's other trials

MED-EL Elektromedizinische Geräte GmbH, most recent start first.

Similar trials

Same condition (Hearing Loss) and phase, most recent start first.